These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24199968)

  • 1. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
    Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
    Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma.
    Choi YW; Kim YH; Lee J; Soh EY; Park TJ; Kim JH
    Hum Pathol; 2015 Oct; 46(10):1557-65. PubMed ID: 26297257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
    Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
    Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
    Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
    J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.
    So AK; Kaur J; Kak I; Assi J; MacMillan C; Ralhan R; Walfish PG
    PLoS One; 2012; 7(7):e40956. PubMed ID: 22911723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of survivin in the pathogenesis of papillary thyroid carcinoma.
    Li JY; Shi J; Sang JF; Yao YZ; Wang XC; Su L
    Genet Mol Res; 2015 Nov; 14(4):15102-11. PubMed ID: 26634473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
    Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
    Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
    Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
    Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH
    Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression and clinical significance of STIP1 in papillary thyroid carcinoma.
    Yuan MH; Zhou RS; She B; Xu HF; Wang JY; Wei LX
    Tumour Biol; 2014 Mar; 35(3):2391-5. PubMed ID: 24163084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus.
    Yan Y; Hu F; Wu W; Ma R; Huang H
    Medicine (Baltimore); 2017 Mar; 96(12):e6393. PubMed ID: 28328831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of galectin-3 immunostaining in fine-needle aspiration cytology specimens from papillary thyroid carcinoma is associated with favorable pathological indices.
    Kim ES; Lim DJ; Lee K; Jung CK; Bae JS; Jung SL; Baek KH; Lee JM; Moon SD; Kang MI; Cha BY; Lee KW; Son HY
    Thyroid; 2012 Dec; 22(12):1244-50. PubMed ID: 22892040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
    Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
    Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
    Yue C; Zhao X; Tian C; Jin Y; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance.
    Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D
    Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
    Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
    J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
    Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
    Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.